Parkinson's Disease and Stem Cells

Parkinson's Disease and Stem Cells: The Challenges That Lie Ahead

While the results of this study are intriguing, they also reveal the need for additional research. For example, the transplanted cells did not survive in 6 of the 25 rats treated, and 5 of the animals developed tumors near the site of the transplants within the first 9 weeks. These complications illustrate the importance of learning how to control and manage how the stem cells become dopamine-producing brain cells before planning similar studies in humans.
 
Also, little is known about the different types of stem cells and Parkinson's disease. Researchers need to better understand the fundamental biology of stem cells and neural precursor cells before such technologies can be used to treat this disease in a safe, effective, and predictable manner.
 
Until important questions like these are answered, treating Parkinson's disease through stem cell transplantation will still be considered an experimental therapy.
 
Know the Signs - Concussion Safety

Parkinson's Disease Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.